April 27, 2012—340B providers should prepare for the possibility of an audit by taking stock of their policies and procedures for avoiding duplicate discounts and drug diversion, a hospital and health-center network recently test-audited by the Office of Pharmacy Affairs (OPA) counseled others during an April 25 webinar.
In addition to self-auditing, the 340B program managers advised webinar participants to review their listings in OPA’s covered entity database for accuracy, educate their employees about 340B requirements, make sure that their state Medicaid office knows whether they carve their 340B drugs “in” or “out,” and otherwise identify and resolve potential problems “before an audit is at your doorstep.”
You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register. Already registered? Click here to login. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)